[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-rigel-pharmaceuticals-inc-nasd330193802b-b32b-7399-b3a4-f734dafddbfb":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":21,"enrichStatus":19,"triageKind":18,"triageImportance":18,"expandEligible":18,"summarizeEligible":18,"eventEligible":18,"eventType":18,"eventAction":18},"rigel-pharmaceuticals-inc-nasd330193802b-b32b-7399-b3a4-f734dafddbfb","1733022061000","Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Sees Significant Decline in Short Interest","Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 462,700 shares,  a decrease of 30.0% from the October 31st total of 661,200 shares. Approximately 2.7% of the company's stock are sold short. Based on an average daily trading volume, of 198,500 shares, the short-interest ratio is currently 2.3 days.","https://www.marketbeat.com/instant-alerts/rigel-pharmaceuticals-inc-nasdaqrigl-sees-significant-decline-in-short-interest-2024-11-29/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"\",\"-\"]","[{\"name\":\"\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/blockchains/.png\"},{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN"]